| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | — |
| R&D Expense | $53.9M | -3.1% |
| SG&A Expense | $20.6M | -24.5% |
| Operating Income | -$64.5M | +22.2% |
| Net Income | -$119.8M | -45.2% |
| EPS (Basic) | -$1.42 | +34.9% |
| EPS (Diluted) | -$1.42 | +34.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.9M | +199.6% |
| Short-term Investments | $13.9M | +0.0% |
| Current Assets | $54.4M | +45.8% |
| Total Assets | $54.8M | +42.9% |
| Current Liabilities | $71.2M | +113.0% |
| Total Liabilities | $72.0M | +109.8% |
| Stockholders' Equity | -$17.1M | -522.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.2M | +29.3% |
| Investing Cash Flow | $13.9M | +5.3% |
| Financing Cash Flow | $74.5M | +169.2% |